Page 30 - Anjali Singh

Visa relaxation shot in the arm after Bangladesh medical tourists dipped

Between April and September 2024-25, major players reported an almost 25-40 per cent decline in medical tourist flow from Bangladesh

Hero MotoCorp Q3FY25 results: Net profit up 1.3%, revenue rises 4.8%

The company said that on a standalone basis, it reported its highest-ever revenue for the first nine months of the financial year, reaching Rs 30,818 crore, up 10 per cent

CNH launches engine plant in Greater Noida, targets 90% localisation

The company has invested $15 million to localise the 2.8L F28 engine, which was developed in Europe, to reduce import dependence and improve cost efficiency

Emcure Pharmaceuticals Q3FY25: Profit grows 35.4%, revenue soars 17.6%

Sequentially, the revenue from operations fell by 1.9 per cent, with net profit also falling by 20.9 per cent

Ola Electric enters EV motorcycle segment with launch of Roadster X series

Deliveries for the Roadster series are set to begin in mid-March. The company has been teasing the launch of its electric motorcycles multiple times

Zydus Lifesciences Q3 results: Profit soars 29.6%, revenue grows 16.9%

The company's India business, comprising both formulations and consumer wellness divisions, contributed 38 per cent of consolidated revenue

Metropolis Healthcare Q3 results: Net profit soars 15%, revenue up 10.8%

On a sequential basis, the company's revenue declined by 7.7 per cent, while PAT also fell by 32.5 per cent

JB Chemicals Q3 results: Profit rises 21.6% to Rs 162 cr, revenue up 14%

Gross margins stood at 67.1 per cent for Q3FY25 and 66.5 per cent for 9M FY25

JK Tyre and Industries Q3 FY25: Profit down 76.6%, revenue falls 0.3%

JK Tyre is focusing on the premiumisation of its product range across various segments, aiming to enhance profitability

Eris Lifesciences Q3FY25 results: Profit skids 18.6%, revenue up 49.6%

This quarter, the organic domestic branded formulations business grew by 12 per cent Y-o-Y, whereas revenue from the branded formulations segment grew by 35 per cent Y-o-Y

2-wheeler market sees mixed Jan; Royal Enfield, TVS gain, Hero, Bajaj slip

"The mixed performance in the two-wheeler market isn't driven by a fundamental shift but rather a tactical one"

India's medical tourism poised for expansion with relaxed visa rules

Industry reports estimate that India's medical tourism market was valued at $7.69 billion in 2024, with approximately 7.3 million foreign patients travelling to India for medical treatment

Budget 2025: Tax relief, policy push to boost electric two-wheeler demand

The Budget also placed a strong emphasis on the gig economy, a sector that plays a crucial role in last-mile deliveries using electric two-wheelers

Budget FY26: Boost for cancer care; gig workers under health cover

The government will establish cancer care centres in every district across India by FY25

Sun Pharma Q3FY25 results: Net profit soars 15%, revenue up 10.5%

Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent. Both profit and revenue were in line with Bloomberg estimates

Sun Pharma Q3FY25 results: Net profit soars 15% to Rs 2,903.3 crore

Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent

GBS in parts of Maharashtra: Likely reasons for disease's outbreak

Infected water source likely the reason for rare neurological condition, say doctors

Cipla Q3 result: PAT soars 48.7% to Rs 1,570.5 cr , revenue grows 7.1%

Cipla's stock was up 3 per cent during the day's trade on the BSE in the afternoon

Piramal Pharma Q3 FY25 results: PAT falls 63% to Rs 3.6 cr, revenue up 12%

Sequentially, revenue from operations declined by 1.67 per cent, with PAT falling 83.7 per cent

High-level team deployed to Maharashtra to tackle GBS cases in Pune

The team will assist the state health department in implementing critical public health measures and managing the situation effectively